Odysight.ai Q2 Revenue Up 16% but H1 Loss Widens; Cash Burn Accelerates
ODYS sits 94% above its 52-week low of $2.6.
Summary
Odysight.ai reported Q2 revenue up 16% to $420K, but H1 revenue fell 79% and net loss widened to $9.5M. Cash dropped to $17.2M with management guiding 12-month runway.
Key Events · Earnings and Guidance · ODYS
-
Q2 Revenue Up 16%
Q2 2026 revenue was $420K, up from $362K in Q2 2025, driven by new project commencements and progress on existing projects.
-
H1 Revenue Plunges 79%
Six-month revenue fell to $502K from $2,427K in H1 2025, primarily due to the absence of the Fortune 500 medical company arrangement derecognized in Q1 2025.
-
Net Loss Widens to $9.5M
H1 2026 net loss was $9.5M, up from $8.3M in H1 2025, driven by lower gross profit and higher sales and marketing expenses.
-
Cash Burn Accelerates
Cash and equivalents fell to $17.2M from $25.7M at year-end 2025; operating cash outflow was $8.7M in H1 2026.
Analysis · ODYS · Technology
Odysight.ai's Q2 revenue grew 16% year-over-year to $420K, but the six-month picture is grim: revenue fell 79% to $502K and net loss widened to $9.5M. Cash dropped to $17.2M from $25.7M at year-end, and the company burned $8.7M in operating activities during H1. Management says cash lasts at least 12 months, but the ATM program remains untapped. The $14.1M backlog offers some visibility, but the company's survival depends on converting that backlog and raising capital.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 29.6% of the 1615 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ODYS was trading at $5.04 on NASDAQ in the Technology sector, with a market capitalization of approximately $70.6M. The 52-week trading range was $2.60 to $11.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.